Aceclofenac/Eperisone

醋氯芬酸/乙哌立松

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAceclofenac/Eperisone
Drug Alias Name乙哌立松/醋氯芬酸Eperisone+aceclofenac醋氯芬酸+乙哌立松Eperisone/aceclofenacAceclofenac+Eperisone +[8] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersCyclooxygenases inhibitors
TargetsVoltage-gated calcium channelCyclooxygenases
Therapy Area/IndicationsLow Back Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Eperisone HydrochlorideAceclofenac
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNavipharm Co
China Registration ClassN/A

Develop Information

Active CompaniesNvp Healthcare
Inactive CompaniesN/A
Active IndicationsLow Back Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A